GET THE APP

Synthesis and anticancer evaluation of some fused pyrazolopyrimidines and their S-acyclic nucleosides | Abstract

Der Pharma Chemica
Journal for Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Sciences and Computational Chemistry

ISSN: 0975-413X
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission Systemof respective journal.

Abstract

Synthesis and anticancer evaluation of some fused pyrazolopyrimidines and their S-acyclic nucleosides

Author(s): Aymn E. Rashad, Ahmed H. Shamroukh, Dalia A. A. Osman,Samir T. Gaballah,Ahmed I. Hashem,Hatem S. ali, and Farouk M. E. Abdel-Megeid

6-Mercapto-1-(9-Methyl-5,6-dihydronaphtho[1',2':4,5]thieno[2,3-d]pyrimidin-11-yl)-1H-pyrazolo[3,4-d]pyrimidin- 4-one (2) was prepared and used as a key compound for the preparation of some S-acyclic nucleosides of pyrazolo[3,4-d]pyrimidines 4-9. Also, the synthesis and structure characterization of pyrazolo[3,4- d][1,3]thiazolidino[3,2-a]pyrimidine 10 and pyrazolo[3,4-d][1,3]-thiazolo[3,2-a]pyrimidine 11 were described. Moreover, the cytotoxicity and in vitro anticancer evaluation of the prepared compounds have also been assessed against breast MCF-7 cancer and liver HepG2 cancer cell lines with investigation the effect of the synthesized compounds on the expression of urokinase plasminogen activator (uPA). The results revealed that, compounds 8 and 7 revealed promising anticancer activity compared to the activity of the commonly used anticancer drug, doxorubicin with inhibiting the expression of uPA.


PDF

Select your language of interest to view the total content in your interested language

30+ Million Readerbase
SCImago Journal & Country Rank
Google Scholar citation report
Citations : 23677

Der Pharma Chemica received 23677 citations as per Google Scholar report

Der Pharma Chemica peer review process verified at publons
Der Pharma Chemica- Journals on pharmaceutical chemistry